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A recent report of the Health Effects
Institute (HEI), Research Priorities for
MobileAir Toxics (1), provides information
on research capable of narrowing uncer-
tainties related to health effects of specific
mobile-source air pollutants. The report,
developed at a workshop in Monterey,
California, 4-6 December 1992, provides
research recommendations for four mobile-
source toxic air pollutants specified in the
Clean Air Act [formaldehyde, benzene,
butadiene, and polycyclic organic matter
(POM)], as well as for methanol, an
important alternative fuel. HEI planned
the workshop in collaboration with repre-
sentatives of the U.S. EPA, California
EPA, California Air Resources Board, and
the automotive and petroleum industries.
Scientists from academia, industry, and
government participated in working
groups on specific compounds. Although
cancer was the primary health effect for
most compounds, there was also much dis-
cussion of noncancer endpoints. HEI's
report focuses on research needs related to
understanding the effects ofthese agents at
concentrations in the ambient air.
Section 202(l)(2) of the 1990 Clean
Air Act Amendments deals with regulation
of mobile-source air toxics. It specifies
that within 54 months after the date ofthe
enactment of the amendments of 1990,
the EPA
Administrator shall promulgate (and from
time to time revise) regulations. .to control
hazardous air pollutants from motor vehicles
and motor vehicle fuels. The regulations shall
contain standards for such fuels or vehicles, or
both, which the Administrator determines
reflect the greatest degree ofemission reduction
achievable through the application oftechnolo-
gy which will be available.... The regulations
shall, at a minimum, apply to emissions ofben-
zene and formaldehyde.
The regulations are to be based on a
study by EPA (2) also specified in the
amendments [202(l)(1)]. "The study shall
focus on those categories of emissions
which pose the greatest risk to human
health or about which significant uncer-
tainties remain, including the emissions of
benzene, formaldehyde, and 1,3-butadiene."
In another part of the act [211(k)(10)],
toxic air pollutants are defined as benzene,
1,3-butadiene, POM, acetaldehyde, and
formaldehyde. The HEI workshop fo-
cused on research that might decrease
uncertainties in risk assessments for these
pollutants before standards are set for
them.
Research Recommendations
In this meeting report, we summarize the
research that each working group decided
was of the highest priority for providing
information to decrease the uncertainty in
risk assessments for these compounds. For
four of the five working groups (all but
methanol), cancer was the main health
effect ofconcern.
Benzene
Human exposure to benzene causes aplas-
tic anemia, chromosome aberrations, and
acute nonlymphocytic leukemia (ANLL).
These effects result from exposure to the
high levels ofbenzene that were previously
prevalent in the workplace. A critical ques-
tion is whether any or all of these effects
can also be produced at the low concentra-
tions that occur in ambient air. In ani-
mals, benzene is a multisite carcinogen,
but there is no useful animal model ofben-
zene-induced leukemia. The benzene
working group recommended the follow-
ing research to reduce critical uncertainties
in risk assessment for benzene:
ExposureAssessment
* Describe and characterize microenvi-
ronments that create substantial oppor-
tunities for benzene exposure.
HealthEffects
* Conduct studies to determine whether
benzene causes solid tumors and hema-
tological malignancies other than
ANLL in humans. This could be done
by following up existing worker cohorts
or by studying worker cohorts now
being established in China.
* Develop specific markers ofexposure to
use in epidemiologic studies to clarify
the shape ofthe dose-response curve in
the low-dose region.
* Develop a suitable animal model to
conduct mechanistic studies ofbenzene
carcinogenesis. Questions to be ad-
dressed in animal models include the
following: What is the mechanism by
which combinations of benzene me-
tabolites produce greater-than-additive
cytogenetic and hematopoietic effects?
What are the critical target genes and
cells for benzene's effects? Is aplastic
anemia an essential step in benzene-
induced leukemia? What is the role of
benzene-induced changes in cytokines
and growth factor pathways relevant to
leukemia?
1,3-Butadiene
Butadiene is used in production ofsynthet-
ic rubber and is also a combustion product.
It causes tumors in rats and mice, and there
is highly suggestive evidence that it causes
cancer in humans exposed occupationally.
The EPA and the International Agency for
Research on Cancer (IARC) have classified
butadiene as a probable human carcinogen.
Major uncertainties in the risk assessment
are in extrapolation of potency from ani-
mals to humans. Human studies do not
provide a sufficient basis for determining
dose response. Extrapolation from animals
is difficult because ofdifferences in potency
and a different spectrum oftumors in mice
and rats. To address these uncertainties,
the butadiene working group designated
the following high-priority research recom-
mendations:
ExposureAssessment
* Characterize emissions from both on-
road and off-road vehicles and the
effects ofreformulated fuels.
HealthEffects
* Determine rates of formation and me-
tabolism ofpotentially toxic metabolites
in target tissues (liver, heart, lung, bone
marrow, lymphatic tissue) and nontar-
get tissue in humans, nonhuman pri-
mates, and rodents. Complete the
development and validation ofa physio-
logically based butadiene dosimetry
model that predicts dose of butadiene
and epoxides in target and nontarget tis-
sues in rodents, nonhuman primates,
and humans.
* Determine whether butadiene induces
mutations and, ifso, the frequency and
mutational spectra in both laboratory
animals and humans.
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* Identify the cancer-related DNA ad-
ducts produced by butadiene and its
metabolites and develop sensitive meth-
ods for their detection in human body
fluids and tissues. The goals are to
develop biomarkers to assess uptake and
metabolism ofbutadiene, provide mech-
anistic insights about butadiene carcino-
genesis, and provide information on
individual variability in butadiene
metabolism.
* Develop a model oftumor development
to elucidate mechanisms of chemical
leukemogenesis in both humans and
mice.
* Carry out epidemiology studies on new
populations with higher exposures to
expand and confirm findings from previ-
ous studies and to evaluate biomarkers
and reproductive outcomes.
Formaldehyde and OtherAldehydes
Formaldehyde has been designated a proba-
ble human carcinogen by EPA and [ARC.
The major uncertainty in the unit cancer
risk estimate, which is based on a study of
nasal tumors (squamous cell carcinoma) in
F344 rats, is due to the steep dose response
observed in rats. Epidemiologic studies pro-
vide support for formaldehyde as a carcino-
gen, but these studies have not been used in
quantitative risk assessments by the U.S.
EPA or California EPA. Although formal-
dehyde risk assessments have focused only
on cancer, the formaldehyde working group
concluded that there is aneed to understand
better whether there are possible noncancer
effects ofexposure to formaldehyde at ambi-
ent exposures.
ExposureAssessment
* Conduct research to understand the
total human exposure to aldehydes,
including distribution of exposures to
formaldehyde amongvarious groups and
the occurrence ofpeakexposures.
Cancer
* Investigate metaplasia in monkeys using
existing tissue blocks from prior formal-
dehyde studies. This may enable devel-
opment ofdose-response information in
a species more similar to humans than
rodents for an endpoint that may be on
the pathway to tumor formation.
* Undertake a meta-analysis of the best
existing epidemiologic studies to develop
a better estimate of the human dose-
response relation for formaldehyde.
* DNA-protein crosslinks have been used
as a measure of tissue dose offormalde-
hyde. Enhanced understanding of the
reaction of formaldehyde with proteins
and DNA is needed.
NoncancerEffects
* Investigate cellular and subcellular
mechanisms ofirritant effects to under-
stand adaptation. Conduct dose-
response studies of the effects of alde-
hydes in combination with other
chemicals.
* Investigate the mechanisms associated
with effects on pulmonary responses.
This work should include efforts to
develop animal models and human in
vitro systems because human exposures
to formaldehyde may not be possible.
* Investigate the molecular basis of in-
creased aldehyde susceptibility due to
polymorphisms in aldehyde dehydroge-
nase.
Methanol
The use of methanol as a fuel for motor
vehicles would result in exposure to low
concentrations ofmethanol via inhalation,
dermally from spilling, and even possibly
by ingestion. It is well known that high-
level exposures to methanol can cause
death from metabolic acidosis and damage
to the visual system, including blindness.
Formate is thought to be the metabolite
responsible for such effects. Because of
species differences in metabolism ofmeth-
anol, rodent studies are not an adequate
model for studying effects of methanol
exposure at high levels. Animals with
induced folate deficiency are more sensi-
tive to methanol. Methanol research
should investigate effects of potential
human exposures and identify groups of
the population that may be at greater risk.
ExposureAssessment
* Develop and validate exposure models
to estimate exposure concentrations
and routes ofexposure in specific expo-
sure scenarios. Conduct ambient and
personal monitoring to determine the
distribution ofexposures.
Pharmacokinetics
* Determine the pharmacokinetics of
methanol and formate during pregnan-
cy in rats, mice, and nonhuman pri-
mates. Include animals with reduced
levels of folate to determine whether
exposure to methanol alters folate
metabolism.
* Conduct human pharmacokinetic
studies to develop a physiologically
based pharmacokinetic model to quan-
tify the disposition of methanol and
formate in individuals with a range of
folate levels.
* Investigate metabolism in target or-
gans, including brain, testes, retina,
and optic nerve.
HealthEJffects
* Conduct studies of developmental
effects, including neurobehavioral end-
points, in rats and nonhuman primates
with both normal and folate-deficient
status.
* Carry out experimental human studies
and epidemiologic studies to assess
neurobehavioral and visual effects of
short-term exposures.
* Conduct chronic animal studies ofneu-
rotoxic, visual, and neuroendocrine
endpoints, using animals with normal
and reduced folate levels.
Polycyclic Organic Matter
Polycyclic organic matter is a complex pol-
lutant category. It is defined in Section
112, title II, ofthe Clean Air Act as a dass
oforganic compounds with more than one
benzene ring and a boiling point of 100°C
or higher. POM includes polycyclic aro-
matic hydrocarbons, heterocyclics, and
other subclasses like lactones. POMs with
five or more rings are generally associated
with particles, whereas those with four or
fewer are semivolatile and partitioned
between the partide and gas phases. Mo-
bile sources contribute to human exposure
to POM, but most compounds are not
unique to mobile sources. Cancer is the
potential health effect of concern for air-
borne exposures to POM, but the potential
magnitude of health effects from environ-
mental exposures is uncertain. There is
evidence that some occupational exposures
to POMs cause increased incidence oflung
cancer.
Cancer
* Cross-validate different animal bioassay
models for cancer in comparison with
human data. Human epidemiological
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data are available for a small number of
POMs for which data from animal
models are also available.
* Determine the potential role in lung
cancer ofingested POMs (from the diet
and from lung clearance of particles)
compared to inhaled POMs.
Biomarkers
* Identify biomarkers of exposure to
POMs and links to adverse health
effects. Develop information to under-
stand the relation between exposure
and markers of dose and effects in tar-
get organs, such as protein and DNA
adducts and genetic changes.
RiskAssessmentMethods
* Evaluate various risk assessment meth-
ods that have been used for POMs
(extrapolation from epidemiologic data,
extrapolation from animal inhalation
data, comparative potency using animal
and human data, benzo[a]pyrene "toxi-
cs equivalence factor method") to deter-
mine the best approach.
Conclusions
The research recommendations summa-
rized here, and the more extensive sets of
recommendations presented in- HEI's
report (1), are aimed at all organizations
funding research on the health effects ofair
pollutants and are not intended to be
restricted to HEI's planning needs. As
with any research, it is difficult to make
predictions about where particular paths
will lead, how many branches they may
have, or how long it will take to reach their
end. We can, in fact, only be certain that
there will be major advances crucial to
understanding the health impact ofair tox-
ics that were not predicted by anyone at
HEI's workshop. Therefore, we stress the
need for research organizations to maintain
flexibility and to respond to rapid develop-
ments.
Specification of these compounds in
HEI's report should not be interpreted as
meaning that they are necessarily the com-
pounds in motor vehicle emissions that
present the greatest risk to health. HEI
and other organizations are assessing infor-
mation on emissions, exposure, and toxici-
ty ofa large number ofcompounds derived
from automotive emissions. This assess-
ment must consider new emissions result-
ing from changes in fuels, additives,
engines, and emissions-control technology,
which must not cause an unreasonable
health risk.
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THE MOST RECENT Splmns issue of the Environmental Health Perspectives Supplements,
Vol. 10_1, Supplement 1, is the complete collection of Technical Report
abstracts through 1992 as taken from the published reports of the
National Cancer Institute Bioassay Program (1971-1978) and its
successor, the National Toxicology Program. Because the Technical
Report series now represents over 400 volumes, it was felt there
was a need to compile a summary of all chronic tumor studies into
a single reference volume.
To order your copy, contact:
GOVERNMENT PRINTING OFFICE, WASHINGTON, DC 20402
or call 202-512-2406.
258 Environmental Health Perspectives